Teradyne Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Teradyne (TER) PT Lowered to $126 at Northland
July 26, 2024 6:52 AM EDTNorthland analyst Gus Richard lowered the price target on Teradyne (NASDAQ: TER) to $126.00 (from $136.00) while maintaining a Market Perform rating.
The analyst comments "TER guidance was disappointing, as the upside of Semitest was offset by weakness in IA and System Test.... More
Teradyne (TER) PT Lowered to $160 at Cantor Fitzgerald
July 26, 2024 6:50 AM EDTCantor Fitzgerald analyst C.J. Muse lowered the price target on Teradyne (NASDAQ: TER) to $160.00 (from $180.00) while maintaining a Neutral rating.
The analyst comments "Teradyne posted a solid beat followed by a modest miss, resulting in combined 2Q/3Q rev/EPS tracking to $1.44B/$1.62 vs. cons of $1.41B/$1.62 coming in. For a stock that rallied ~50% over the last 3 months, this was clearly not good enough.... More
Teradyne (TER) PT Lowered to $151 at Goldman Sachs
July 26, 2024 5:53 AM EDTGoldman Sachs analyst Toshiya Hari lowered the price target on Teradyne (NASDAQ: TER) to $151.00 (from $161.00) while maintaining a Conviction Buy rating.
The analyst comments "Although Teradynes 3Q24 outlook fell short of elevated expectations and we are reducing near-term estimates to... More
Teradyne (TER) PT Lowered to $140 at Stifel
July 25, 2024 1:51 PM EDTStifel analyst Brian Chin lowered the price target on Teradyne (NASDAQ: TER) to $140.00 (from $150.00) while maintaining a Hold rating.
The analyst comments "Teradynes expectations didnt change (much), but the markets (including ours) had. We did expect a slightly better update on... More

